Wall Street analysts forecast that Teleflex (TFX) will report quarterly earnings of $3.73 per share in its upcoming release, pointing to a year-over-year decline of 4.1%. It is anticipated that revenues will amount to $925.96 million, exhibiting an increase of 16.4% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed t ...

Tilray Brands (NASDAQ: TLRY), like many other cannabis stocks, has taken investors on a wild roller-coaster ride the past few years, though for the most part, that ride has been downward. The stock soared by more than 10 times in the months after its 2018 IPO. But then, the optimism faded. Over the past five years, Tilray's share price has collapsed by 97%. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" prov ...

Many pharmaceutical companies are looking to develop and market the now highly popular GLP-1 drugs, which help treat diabetes, help patients lose weight, and reduce their risk of a range of conditions linked to obesity. The drugmakers that lead this market over the next decade could reap substantial financial benefits for themselves and their shareholders. But what if companies outside of the pharmaceutical industry benefit as well? One excellent candidate to do so is DexCom (NASDAQ: DXCM). Let's conside ...

UFP Technologies (NasdaqCM:UFPT) Q4 2025 Earnings call February 25, 2026 08:30 AM ET Company ParticipantsAndrew Cooper - Director of Equity ResearchJeff Bailly - Chairman and CEOJustin Ages - Director of Equity ResearchRon Lataille - VP, Treasurer, and CFOConference Call ParticipantsMax Michaelis - Equity Research AnalystNone - AnalystOperatorGood day, welcome to the UFP Technologies fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, pleas ...

UFP Technologies (NasdaqCM:UFPT) Q4 2025 Earnings call February 25, 2026 08:30 AM ET Speaker3Good day, welcome to the UFP Technologies fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad. To withdraw your question, pleas ...

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $200.5 billion by market cap, ABT is a global leader in the large and growing in-vitro diagnostic market and its products include pharmaceuticals, nutritional, diagnostics, and vascular products. Companies worth $200 billion or more are generally described as “mega-cap stocks,” and ABT definitely fits that description, with its market cap exceeding this threshold, reflecting ...

LivaNova (NasdaqGS:LIVN) Q4 2025 Earnings call February 25, 2026 08:00 AM ET Company ParticipantsAhmet Tezel - Chief Innovation OfficerAlex Shvartsburg - CFOAnthony Petrone - Managing Director and Equity ResearchBrianna Gotlin - Vice President of Investor RelationsJohn McAulay - Associate VPVladimir Makatsaria - CEOConference Call ParticipantsAdam Maeder - Managing Director and Senior Research AnalystBrett Fishman - VP and Senior Equity Research AnalystDavid Rescott - Senior Research AnalystMichael Polark - ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (“STSS” or the “Company”) (NASDAQ: STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. (“The Tie”), the leading provider of institutional-grade digital asset analytics, compliant communications, and infrastructure services, today announced a strategic collaboration to strengthen Solana’s institutional infrastructure and expand institutional access to the ecosystem. Under the collaboration, STSS w ...

CLEARWATER, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the fourth quarter of fiscal year 2025 will be released before markets open on Tuesday, March 10th. Management will host a conference call at 8:00 a.m. Eastern Time on Tuesday, March 10th, to discuss the results of the quarter, f ...

Key Takeaways Alcon's Q4 core EPS rose 8.3% Y/Y but missed, as revenues grew 9%, and shares fell 3%.ALC's Surgical sales climbed 9%, led by equipment launches and PanOptix Pro growth.Alcon projects 2026 sales growth of 5%-7% and core EPS growth of 9%-12%.Alcon, Inc. (ALC)  delivered fourth-quarter 2025 core earnings per share (EPS) of 78 cents, up 8.3% from the year-ago quarter’s figure. At the constant exchange rate or CER, the figure rose 2% year over year. The metric missed the Zacks Consensus Estimate b ...